News

Published on 10 Apr 2024 on Schaeffer's Investment Research via Yahoo Finance

Pharma Stock Could Push Back Toward Highs


Article preview image

The shares of pharma stock Bausch Health Companies Inc (NYSE:BHC) have taken a tumble since their recent April 3 nearly two-year high of $11.46. Starting off this week on a sour note with a 6.9% loss -- BHC's worst daily percentage drop since September -- the stock is looking to extend its slide today, down 2.5% at $9.03 at last glance.

For those curious about buying in on the dip, however, the recent pullback has BHC within one standard deviation of its 50-day moving average, a trendline with historically bullish implications. According to Schaeffer's Senior Quantitative Analyst Rocky White, the equity has two similar signals in the past three years, after which it was higher one month later each time, averaging an impressive 14.6% gain. 

BHC apr10BHC apr10

NYSE.BHC price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Bausch Health stock gains after appeals court affirms ruling in Norwich patent case

Bausch Health (BHC) experienced a 7.4% increase as an appeals court ruled in favor of the company...

Seeking Alpha 11 Apr 2024

Bausch Health stock gains 6% amid lawsuit win, retains buy rating at Jefferies By Investing.com

On Thursday, Bausch Health Companies Inc. (NYSE:BHC) received a reaffirmation of a Buy rating and...

Investing.com 11 Apr 2024

Bausch Health wins appeal in XIFAXAN patent case By Investing.com

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its subsidiary Salix Pharmaceuticals announc...

Investing.com 11 Apr 2024

Pharma Stock Could Push Back Toward Highs

The shares of pharma stock Bausch Health Companies Inc (NYSE:BHC) have taken a tumble since their...

Schaeffer's Investment Research via Yahoo Finance 10 Apr 2024

Canada shares lower at close of trade; S&P/TSX Composite down 0.02%

Canada shares lower at close of trade; S&P/TSX Composite down 0.02%

Investing.com 8 Apr 2024

Bausch Health stock drops after suing Amneal Pharma over Xifaxan generic

Bausch Health's stock falls 7% as it files a patent lawsuit against a generic version of its bowe...

Seeking Alpha 8 Apr 2024

Here's Why Bausch Health (BHC) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new ...

Zacks via Yahoo Finance 3 Apr 2024

Bausch's UCERIS now covered by public drug plans in five provinces

Bausch Health Companies Inc. (NYSE: BHC )(TSX:BHC) has announced the inclusion of UCERIS®...

Investing.com 3 Apr 2024

Bausch's UCERIS now covered by public drug plans in five provinces By Investing.com

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) has announced the inclusion of UCERIS® (budesoni...

Investing.com 3 Apr 2024

Chou RRSP Fund Exits Home Capital Group with Notable Portfolio Impact

Insight into Chou RRSP Fund (Trades, Portfolio)'s Q4 2023 Investment Moves and Portfolio Adjustme...

GuruFocus.com via Yahoo Finance 1 Apr 2024